Prevalence of Tramadol Consumption in First Seizure Patients; a One-Year Cross-sectional Study
Archives of Academic Emergency Medicine,
Vol. 3 No. 4 (2015),
1 November 2015
,
Page 159-161
https://doi.org/10.22037/aaem.v3i4.295
Abstract
Introduction: Previous studies have shown that there is a probability of seizure even with therapeutic doses of tramadol. Yet, no accurate data exist regarding this problem in Iran. Therefore, the present study aimed to evaluate the prevalence of tramadol consumption in patients with first seizure referred to the emergency department (ED). Methods: In the present retrospective one-year cross-sectional study, all patients who were referred to the ED of Poursina Hospital, Rasht, Iran, with the complaint of first seizure were evaluated. Demographic data and data regarding history of tramadol consumption, duration, total dose, last dose, and time passed from the last dose of consumption were recorded and analyzed regarding the study questions using SPSS 20. Results: 383 (68.9%) out of the 556 patients referred to the ED, were experiencing their first seizure (mean age 26.43 ± 6.48 years; 70.5% male). 84 (21.9%) patients had recently used tramadol. History of seizure in the family of tramadol consumers was significantly lower (3.6% compared to 11%; p = 0.036). Mean total tramadol consumption dose in the last 24 hours was 140.17 ± 73.53 mg (range: 50-300 mg). Duration of tramadol consumption was less than 10 days in 84.5% (df: 2; χ2 = 96.1; p < 0.001). In addition, 62 (73.8%) patients had seizure within 6 hours of consumption (df: 3; χ2 = 29.5; p < 0.001). Conclusion: Results of the present study showed that 21.9% of the patients with first seizure had a history of tramadol consumption. Seizure following tramadol consumption is more prevalent in the initial 10 days and within 6 hours of consumption. In addition, it seems that lower doses of tramadol may also induce seizure.- Seizures
- tramadol
- prevalence
- epidemiology
How to Cite
References
Mehrpour M. Intravenous Tramadol-Induced Seizure: Two Case Reports. Iran J Pharmacol Therapeut. 2005;4(2):146-7.
Shadnia S, Soltaninejad K, Heydari K, Sasanian G, Abdollahi M. Tramadol intoxication: a review of 114 cases. Hum Exp Toxicol. 2008;27:201–5.
Derakhshanfar H, Kalantari Meibodi M, Kariman H, Arhamidolatabadi A, Safari S. Substance Abuse among Drivers of Motor Vehicle Collisions. Trauma Mon. 2012;2012(01, Apr):236-8.
Tashakori A, Afshari R. Tramadol overdose as a cause of serotonin syndrome: a case series. Clin Toxicol (Phila). 2010;48(4):337-41.
Pedramfar P, Borhani Haghighi A. Tramadol Induced Seizure: Report of 106 Patients. Iran Red Crescent Med J. 2010;12(1):49-51.
Hassanian Moghaddam H, Pajoumand A. A oneyear epidemiological study of acute poisoning among adults and adolescents admitted to loghman Hospital, Tehran between 2005 and 2006. Pajouhandeh. 2007;12(57):169-76. [Persian].
Jovanovic-Cupic V, Martinovic Z, Nešic N. Seizures associated with intoxication and abuse of tramadol. Clin Toxicol. 2006;44(2):143-6.
Marquardt KA, Alsop JA, Albertson TE. Tramadol exposures reported to statewide poison control system. Ann Pharmacother. 2005;39(6):1039-44.
Baratloo A, Rouhipour A, Forouzanfar M, Rahmati F, Hashemi B. Hypokalemia-Induced Abnormal Movements: Case Report. Trauma Mon. 2013;18(3):141-5.
- Abstract Viewed: 353 times
- PDF Downloaded: 3420 times
- HTML Downloaded: 53 times